Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis

    Feb 10, 2022, 14:05 PM by
    Hello, Today, Thermo Fisher announced a new addition to its leading Applied Biosystems portfolio: a genetic analyzer that customers say is “the most intuitive and flexible sequencer we have ever used.” The Applied Biosystems SeqStudio Flex Series Genetic Analyzer builds on leading CE-technology to support customers performing Sanger sequencing or fragment analysis. Please find the press release below and online here and let me know if you have any questions or would like a high-res product photo.
    Full story
  • PubHive Adds Single Sign-On Integration With Okta

    Feb 10, 2022, 14:05 PM by
    New integration facilitates secure single sign-on (SSO) and user provisioning for life science companies using PubHive’s AI-powered scientific workflow automation SaaS platform
    Full story
  • Alfa Chemistry Demonstrates Ability for Surface Analysis to Facilitate Materials Testing for Alternative Energy Industry

    Feb 10, 2022, 14:05 PM by
    Full story
  • New BHM® COVID-19 lateral flow test passes UK government assessment

    Feb 10, 2022, 14:05 PM by
    Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces that its new lateral flow test has passed phase 3a testing by the UK government. The new test is more sustainable than traditional lateral flow kits, producing 75% less plastic waste.
    Full story
  • Watson-Marlow launches industry first augmented reality app for Sine pump maintenance

    Feb 10, 2022, 14:05 PM by
    Leading the way in creative customer solutions, Watson-Marlow Fluid Technology Group (WMFTG) has launched the first in a series of augmented reality (AR) apps. Developed to enhance the customer experience and post-sales support for its products, the first app has been built for its Certa Sine pump. This is a pump renowned for meeting the highest standards in hygiene and cleanability, improving process efficiency and minimising total cost of ownership.
    Full story
  • IDT UNVEILS NEW SOLUTION TO ACCELERATE HOMOLOGY-DIRECTED REPAIR GENOME EDITING RESEARCH

    Feb 10, 2022, 14:05 PM by
    Full story
  • Domainex opens a dedicated new facility at Unity Campus to expand research operations

    Feb 10, 2022, 14:05 PM by
    Domainex Ltd., a leading integrated medicines research services partner, today announces it has opened a facility of over 7,000 sq ft at Unity Campus in Sawston – Cambridge’s newest science and technology park encompassing Iconix Park and The Works, and owned by leading regional property and investment firm Howard Group.
    Full story
  • DISYS Launches PVAutomate, an Innovative Healthcare Solution Automating Critical Functions in Pharmacovigilance Operations

    Feb 10, 2022, 14:05 PM by
    Digital Intelligence Systems, LLC (DISYS), a global technology services firm, launches its innovative healthcare automation solution, PVAutomate, which automates critical compliance workflows and data management in pharmacovigilance operations.
    Full story
  • ‘Immune Archetypes’ Of Cancer Could Help Tailor Treatments To Tumors

    Feb 10, 2022, 01:00 AM by User Not Found
    Bio-IT World | Immunotherapies vary widely in their ability to effectively treat patients with cancer, and the reason is the differing immune states of their tumor. Only a finite number of “immune archetypes” exist across all cancers—and these distinct environments are inhabited by more than the T cells targeted by currently marketed immunotherapy drugs.
    Full story
  • Releasing the Potential of Biobatteries

    Feb 9, 2022, 01:00 AM by User Not Found
    Bio-IT World | Imagine batteries made from completely safe, organic, non-combustible, and biodegradable materials. Now imagine that these batteries can be recharged not from an outlet, but from the excess energy of our bodies. Refueling by gathering kinetic energy from our movement, or thermal energy from body heat, or—in what might be the most sci-fi scenario—feeding on the biochemical surplus of sugars coursing through our veins, or even compounds present in our saliva, sweat, or other body fluids. This idea is the biobattery, and the potential uses and benefits are pretty remarkable.
    Full story
  • Follow the Money: AI in Gastroenterology Research, Cloud Infrastructure Provisioning

    Feb 8, 2022, 01:00 AM by User Not Found
    Bio-IT World | Sanofi and Exscientia collaborate to use AI for oncology and immunology treatments, Iterative Scopes using AI in gastroenterology treatments, Quris uses AI for clinical prediction, and more.
    Full story
  • Driving Value in Biopharma R&D through Digital Transformation

    Feb 4, 2022, 01:00 AM by User Not Found
    Bio-IT World | Rapid scientific innovation is dependent on streamlining three key capabilities: improving data usability, enabling global cross-team collaboration, and automating scientific workflows. We believe that digital technologies should serve as the foundation that connects your data, people, and processes together to drive scientific discovery. From our perspective, the companies that embrace digital will ultimately win the R&D race.
    Full story
  • AES Clean Technology Accelerates Cleanroom Capabilities with $14.2 million Investment

    Feb 2, 2022, 17:13 PM by
    Full story
  • Scitara joins BioPhorum global collaboration to drive scientific advancements in biopharmaceutical sector

    Feb 2, 2022, 17:13 PM by
    Full story
  • Abzena appoints Kevin Lundquist as Chief Financial Officer

    Feb 2, 2022, 17:13 PM by
    Full story
  • Temedica partners with NOVENTI to enhance Permea generated insights to improve patient care

    Feb 2, 2022, 17:13 PM by
    Full story
  • InsightRX Reports Record Growth in Platform Adoption by Health Systems and Biopharma Companies

    Feb 2, 2022, 17:13 PM by
    Precision dosing intelligence company tripled client base, expanded oncology focus, and developed new drug models in 2021
    Full story
  • DxCG Intelligence Celebrates 25th Anniversary, Launches Version 6.0 with Enhanced Clinical and Pharmaceutical Classification Systems

    Feb 2, 2022, 17:13 PM by
    Cotiviti’s preeminent risk assessment and predictive modeling tool continues to aid in improving healthcare cost and quality
    Full story
  • CD Formulation Provides Tailor-made Solutions for Thickener Excipients for Drug Development

    Feb 2, 2022, 17:13 PM by
    Full story
  • Alfa Chemistry Materials Begins to Supply Carbon fibers for Nanotech Research

    Feb 2, 2022, 17:13 PM by
    Full story
  • «
  • 151
  • 152
  • 153
  • 154
  • 155 (current)
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy